Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Titan Pharma (TTNP)

Titan Pharma (TTNP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Stock Index Futures Tread Water as Investors Brace for Fed Minutes and Powell’s Speech

September S&P 500 E-Mini futures (ESU24) are up +0.01%, and September Nasdaq 100 E-Mini futures (NQU24) are up +0.09% this morning as market participants geared up for the release of the minutes of the...

ESU24 : 5,699.99s (-0.31%)
NQU24 : 19,808.01s (-0.21%)
ZIM : 25.42 (+5.70%)
AMD : 149.87 (+3.29%)
MCD : 295.41 (+0.48%)
HPQ : 37.58 (+1.82%)
LOW : 266.39 (+1.78%)
MDT : 88.24 (-2.08%)
KEYS : 165.03 (+1.96%)
TOL : 154.08 (+1.81%)
AS : 19.29 (+6.87%)
TTNP : 4.14 (+0.98%)
Titan Pharmaceuticals: Q2 Earnings Snapshot

Titan Pharmaceuticals: Q2 Earnings Snapshot

TTNP : 4.14 (+0.98%)
Titan Pharmaceuticals: Q1 Earnings Snapshot

Titan Pharmaceuticals: Q1 Earnings Snapshot

TTNP : 4.14 (+0.98%)
Titan Pharmaceuticals: Q3 Earnings Snapshot

Titan Pharmaceuticals: Q3 Earnings Snapshot

TTNP : 4.14 (+0.98%)
Titan Pharmaceuticals: Q2 Earnings Snapshot

Titan Pharmaceuticals: Q2 Earnings Snapshot

TTNP : 4.14 (+0.98%)
Titan Pharmaceuticals Announces Board Expansion and Management Changes

/PRNewswire/ -- Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) ("Titan" or the "Company") today announced that it has expanded its Board of Directors (the "Board")...

TTNP : 4.14 (+0.98%)
Titan Pharmaceuticals Announces FDA Clearance of IND Application for Nalmefene Implant

/PRNewswire/ -- Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) ("Titan" or the "Company") today announced that the U.S. Food and Drug Administration ("FDA") has...

TTNP : 4.14 (+0.98%)
Activist Investing Discloses 9.9% Ownership Interest in Titan Pharmaceuticals, Inc.

NEW YORK, June 10, 2022 (GLOBE NEWSWIRE) -- David E. Lazar, Chief Executive Officer of Activist Investing LLC (together with its affiliates, “Activist...

TTNP : 4.14 (+0.98%)
Activist Investing Announces 5.6% Ownership Interest in Titan Pharmaceuticals, Inc.

NEW YORK, April 25, 2022 (GLOBE NEWSWIRE) -- Activist Investing LLC (together with its affiliates, “Activist Investing” or “we”), today filed a Schedule...

TTNP : 4.14 (+0.98%)
Titan Pharmaceuticals: Q3 Earnings Snapshot

SAN FRANCISCO (AP) _ Titan Pharmaceuticals Inc. (TTNP) on Monday reported a loss of $1.9 million in its third quarter.

TTNP : 4.14 (+0.98%)

Barchart Exclusives

Can the REMX ETF Rally?
While the REMX ETF’s name implies significant exposure to rare earth metals and minerals, the product’s holdings are primarily invested in lithium-producing mining companies. REMX has been under pressure, but commodity cyclicality suggests that it is in the buying zone below $50 per share. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar